Form 4: Concentrix Corp CEO Caldwell Exercises Options and Sells Shares
SEC Form 4 Filing
Christopher A. Caldwell, President and CEO of Concentrix Corp, exercised stock options and sold a portion of the acquired shares on October 4, 2024.
Summary
- On October 4, 2024, Christopher A. Caldwell, the President and CEO of Concentrix Corp, exercised employee stock options to acquire 12,928 shares of common stock at a price of $31.39 per share.
- Simultaneously, Caldwell sold 9,823 shares of common stock at a weighted average price of $52.7037, with individual sales ranging from $52.30 to $53.19.
- Following these transactions, Caldwell directly owns 241,841 shares of Concentrix Corp.
- The exercised options were originally granted on December 1, 2020, and were set to expire on October 7, 2024.
Sentiment
Score: 5
Explanation: The document is a standard SEC Form 4 filing, reflecting routine transactions. It doesn't inherently convey positive or negative sentiment.
Industry Context
Executive stock option exercises and sales are a common occurrence in publicly traded companies and are closely monitored by investors for insights into management's perspective on the company's future performance.
Stakeholder Impact
- The sale of shares by a high-ranking executive could be perceived negatively by some shareholders, although option exercises and sales are a normal part of executive compensation.
- The transactions have a minimal impact on employees, customers, suppliers and creditors.
Key Dates
| Date | Description |
|---|---|
| 12/01/2020 | Date Employee Stock Options were granted. |
| 10/04/2024 | Date of option exercise and share sale. |
| 10/07/2024 | Expiration date of the Employee Stock Options. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.